The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cetirizine Hydrochloride Tablets Market Research Report 2024

Global Cetirizine Hydrochloride Tablets Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1743889

No of Pages : 105

Synopsis
Cetirizine hydrochloride tablets are usually mixed with lactose, microcrystalline cellulose, silicon dioxide, magnesium stearate and gastric-soluble film-coating premix, and are often used for seasonal rhinitis, perennial allergic rhinitis, Symptomatic treatment of allergic conjunctivitis and pruritus and urticaria caused by allergies.

Global Cetirizine Hydrochloride Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cetirizine Hydrochloride Tablets market research.

Key manufacturers engaged in the Cetirizine Hydrochloride Tablets industry include Sun Pharma, UCB Farchim SA, Yangtze River Pharmaceutical (Group) Co., Ltd., Livzon Pharmaceutical Group Inc., Nanjing Sanhome Pharmaceutical Co.,Ltd., PKU Healthcare Corp., Ltd., Qilu Pharmaceutical Co., Ltd., Jilin Huakang Pharmaceutical Co., Ltd. and Sichuan Hengrui Pharmaceutical Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Cetirizine Hydrochloride Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cetirizine Hydrochloride Tablets market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cetirizine Hydrochloride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Sun Pharma
  • UCB Farchim SA
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Livzon Pharmaceutical Group Inc.
  • Nanjing Sanhome Pharmaceutical Co.,Ltd.
  • PKU Healthcare Corp., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Jilin Huakang Pharmaceutical Co., Ltd.
  • Sichuan Hengrui Pharmaceutical Co., Ltd.
  • Shaixi Taiyuan Pharmaceutical Co., Ltd.
  • Guangdong Guoyuan Sinopharm Co., Ltd.
  • Suzhou Dawnrays Pharmaceutical Co., Ltd.
  • Zhejiang Zhebei Pharmaceutical Co., Ltd.
  • Nanjing Chang'ao Pharmaceutical Co., Ltd.
  • Xinhua Pharmaceutical (Gaomi) Co., Ltd.

Segment by Type

  • 5mg/tablet
  • 10mg/tablet

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Clinic
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Cetirizine Hydrochloride Tablets report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Cetirizine Hydrochloride Tablets Market Overview
1.1 Product Overview and Scope of Cetirizine Hydrochloride Tablets
1.2 Cetirizine Hydrochloride Tablets Segment by Type
1.2.1 Global Cetirizine Hydrochloride Tablets Market Value Comparison by Type (2023-2029)
1.2.2 5mg/tablet
1.2.3 10mg/tablet
1.3 Cetirizine Hydrochloride Tablets Segment by Application
1.3.1 Global Cetirizine Hydrochloride Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Cetirizine Hydrochloride Tablets Market Size Estimates and Forecasts
1.4.1 Global Cetirizine Hydrochloride Tablets Revenue 2018-2029
1.4.2 Global Cetirizine Hydrochloride Tablets Sales 2018-2029
1.4.3 Global Cetirizine Hydrochloride Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cetirizine Hydrochloride Tablets Market Competition by Manufacturers
2.1 Global Cetirizine Hydrochloride Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cetirizine Hydrochloride Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cetirizine Hydrochloride Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Cetirizine Hydrochloride Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cetirizine Hydrochloride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cetirizine Hydrochloride Tablets, Product Type & Application
2.7 Cetirizine Hydrochloride Tablets Market Competitive Situation and Trends
2.7.1 Cetirizine Hydrochloride Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cetirizine Hydrochloride Tablets Players Market Share by Revenue
2.7.3 Global Cetirizine Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cetirizine Hydrochloride Tablets Retrospective Market Scenario by Region
3.1 Global Cetirizine Hydrochloride Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cetirizine Hydrochloride Tablets Global Cetirizine Hydrochloride Tablets Sales by Region: 2018-2029
3.2.1 Global Cetirizine Hydrochloride Tablets Sales by Region: 2018-2023
3.2.2 Global Cetirizine Hydrochloride Tablets Sales by Region: 2024-2029
3.3 Global Cetirizine Hydrochloride Tablets Global Cetirizine Hydrochloride Tablets Revenue by Region: 2018-2029
3.3.1 Global Cetirizine Hydrochloride Tablets Revenue by Region: 2018-2023
3.3.2 Global Cetirizine Hydrochloride Tablets Revenue by Region: 2024-2029
3.4 North America Cetirizine Hydrochloride Tablets Market Facts & Figures by Country
3.4.1 North America Cetirizine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cetirizine Hydrochloride Tablets Sales by Country (2018-2029)
3.4.3 North America Cetirizine Hydrochloride Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cetirizine Hydrochloride Tablets Market Facts & Figures by Country
3.5.1 Europe Cetirizine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cetirizine Hydrochloride Tablets Sales by Country (2018-2029)
3.5.3 Europe Cetirizine Hydrochloride Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cetirizine Hydrochloride Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Cetirizine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cetirizine Hydrochloride Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Cetirizine Hydrochloride Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cetirizine Hydrochloride Tablets Market Facts & Figures by Country
3.7.1 Latin America Cetirizine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cetirizine Hydrochloride Tablets Sales by Country (2018-2029)
3.7.3 Latin America Cetirizine Hydrochloride Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cetirizine Hydrochloride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Cetirizine Hydrochloride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cetirizine Hydrochloride Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cetirizine Hydrochloride Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cetirizine Hydrochloride Tablets Sales by Type (2018-2029)
4.1.1 Global Cetirizine Hydrochloride Tablets Sales by Type (2018-2023)
4.1.2 Global Cetirizine Hydrochloride Tablets Sales by Type (2024-2029)
4.1.3 Global Cetirizine Hydrochloride Tablets Sales Market Share by Type (2018-2029)
4.2 Global Cetirizine Hydrochloride Tablets Revenue by Type (2018-2029)
4.2.1 Global Cetirizine Hydrochloride Tablets Revenue by Type (2018-2023)
4.2.2 Global Cetirizine Hydrochloride Tablets Revenue by Type (2024-2029)
4.2.3 Global Cetirizine Hydrochloride Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Cetirizine Hydrochloride Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cetirizine Hydrochloride Tablets Sales by Application (2018-2029)
5.1.1 Global Cetirizine Hydrochloride Tablets Sales by Application (2018-2023)
5.1.2 Global Cetirizine Hydrochloride Tablets Sales by Application (2024-2029)
5.1.3 Global Cetirizine Hydrochloride Tablets Sales Market Share by Application (2018-2029)
5.2 Global Cetirizine Hydrochloride Tablets Revenue by Application (2018-2029)
5.2.1 Global Cetirizine Hydrochloride Tablets Revenue by Application (2018-2023)
5.2.2 Global Cetirizine Hydrochloride Tablets Revenue by Application (2024-2029)
5.2.3 Global Cetirizine Hydrochloride Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Cetirizine Hydrochloride Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sun Pharma
6.1.1 Sun Pharma Corporation Information
6.1.2 Sun Pharma Description and Business Overview
6.1.3 Sun Pharma Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sun Pharma Cetirizine Hydrochloride Tablets Product Portfolio
6.1.5 Sun Pharma Recent Developments/Updates
6.2 UCB Farchim SA
6.2.1 UCB Farchim SA Corporation Information
6.2.2 UCB Farchim SA Description and Business Overview
6.2.3 UCB Farchim SA Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 UCB Farchim SA Cetirizine Hydrochloride Tablets Product Portfolio
6.2.5 UCB Farchim SA Recent Developments/Updates
6.3 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.3.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.3.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.3.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.3.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.4 Livzon Pharmaceutical Group Inc.
6.4.1 Livzon Pharmaceutical Group Inc. Corporation Information
6.4.2 Livzon Pharmaceutical Group Inc. Description and Business Overview
6.4.3 Livzon Pharmaceutical Group Inc. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Livzon Pharmaceutical Group Inc. Cetirizine Hydrochloride Tablets Product Portfolio
6.4.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
6.5 Nanjing Sanhome Pharmaceutical Co.,Ltd.
6.5.1 Nanjing Sanhome Pharmaceutical Co.,Ltd. Corporation Information
6.5.2 Nanjing Sanhome Pharmaceutical Co.,Ltd. Description and Business Overview
6.5.3 Nanjing Sanhome Pharmaceutical Co.,Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nanjing Sanhome Pharmaceutical Co.,Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.5.5 Nanjing Sanhome Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.6 PKU Healthcare Corp., Ltd.
6.6.1 PKU Healthcare Corp., Ltd. Corporation Information
6.6.2 PKU Healthcare Corp., Ltd. Description and Business Overview
6.6.3 PKU Healthcare Corp., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 PKU Healthcare Corp., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.6.5 PKU Healthcare Corp., Ltd. Recent Developments/Updates
6.7 Qilu Pharmaceutical Co., Ltd.
6.6.1 Qilu Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Qilu Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Qilu Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qilu Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.7.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Jilin Huakang Pharmaceutical Co., Ltd.
6.8.1 Jilin Huakang Pharmaceutical Co., Ltd. Corporation Information
6.8.2 Jilin Huakang Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Jilin Huakang Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jilin Huakang Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.8.5 Jilin Huakang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Sichuan Hengrui Pharmaceutical Co., Ltd.
6.9.1 Sichuan Hengrui Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Sichuan Hengrui Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Sichuan Hengrui Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sichuan Hengrui Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.9.5 Sichuan Hengrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Shaixi Taiyuan Pharmaceutical Co., Ltd.
6.10.1 Shaixi Taiyuan Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Shaixi Taiyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Shaixi Taiyuan Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shaixi Taiyuan Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.10.5 Shaixi Taiyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Guangdong Guoyuan Sinopharm Co., Ltd.
6.11.1 Guangdong Guoyuan Sinopharm Co., Ltd. Corporation Information
6.11.2 Guangdong Guoyuan Sinopharm Co., Ltd. Cetirizine Hydrochloride Tablets Description and Business Overview
6.11.3 Guangdong Guoyuan Sinopharm Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Guangdong Guoyuan Sinopharm Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.11.5 Guangdong Guoyuan Sinopharm Co., Ltd. Recent Developments/Updates
6.12 Suzhou Dawnrays Pharmaceutical Co., Ltd.
6.12.1 Suzhou Dawnrays Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Suzhou Dawnrays Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Description and Business Overview
6.12.3 Suzhou Dawnrays Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Suzhou Dawnrays Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.12.5 Suzhou Dawnrays Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Zhejiang Zhebei Pharmaceutical Co., Ltd.
6.13.1 Zhejiang Zhebei Pharmaceutical Co., Ltd. Corporation Information
6.13.2 Zhejiang Zhebei Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Description and Business Overview
6.13.3 Zhejiang Zhebei Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Zhejiang Zhebei Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.13.5 Zhejiang Zhebei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Nanjing Chang'ao Pharmaceutical Co., Ltd.
6.14.1 Nanjing Chang'ao Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Nanjing Chang'ao Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Description and Business Overview
6.14.3 Nanjing Chang'ao Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nanjing Chang'ao Pharmaceutical Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.14.5 Nanjing Chang'ao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Xinhua Pharmaceutical (Gaomi) Co., Ltd.
6.15.1 Xinhua Pharmaceutical (Gaomi) Co., Ltd. Corporation Information
6.15.2 Xinhua Pharmaceutical (Gaomi) Co., Ltd. Cetirizine Hydrochloride Tablets Description and Business Overview
6.15.3 Xinhua Pharmaceutical (Gaomi) Co., Ltd. Cetirizine Hydrochloride Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xinhua Pharmaceutical (Gaomi) Co., Ltd. Cetirizine Hydrochloride Tablets Product Portfolio
6.15.5 Xinhua Pharmaceutical (Gaomi) Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cetirizine Hydrochloride Tablets Industry Chain Analysis
7.2 Cetirizine Hydrochloride Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cetirizine Hydrochloride Tablets Production Mode & Process
7.4 Cetirizine Hydrochloride Tablets Sales and Marketing
7.4.1 Cetirizine Hydrochloride Tablets Sales Channels
7.4.2 Cetirizine Hydrochloride Tablets Distributors
7.5 Cetirizine Hydrochloride Tablets Customers
8 Cetirizine Hydrochloride Tablets Market Dynamics
8.1 Cetirizine Hydrochloride Tablets Industry Trends
8.2 Cetirizine Hydrochloride Tablets Market Drivers
8.3 Cetirizine Hydrochloride Tablets Market Challenges
8.4 Cetirizine Hydrochloride Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’